Drugs / recombinant MAGE-3.1 antigen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00002952 | Jan 1997 → Aug 2002 | cutaneous melanoma | University of Chicago | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant MAGE-3.1 antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002952 ↗ |